BamSEC and AlphaSense Join Forces
Learn More

Collagenex Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.31
from 10-K 2 pages Executive Officer Compensation Summary
12/34/56
EX-10.30
from 10-K ~10 pages Non-Employee Director Compensation Summary
12/34/56
EX-10.1
from 10-Q 38 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Sub-License Agreement
12/34/56
EX-10.38
from 10-K 2 pages Executive Officer Compensation Summary
12/34/56
EX-10.37
from 10-K ~5 pages Non-Employee Director Compensation Summary
12/34/56
EX-10.30
from 10-K 3 pages Extension and Amendment to Promotion and Cooperation Agreement
12/34/56
EX-10.24
from 10-K 4 pages Second Amendment to Agreement Between Altana Inc. and Collagenex Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 33 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Product License and Supply Agreement Parties
12/34/56
EX-10.2
from 8-K 11 pages Collagenex Pharmaceuticals, Inc. Change of Control Agreement
12/34/56
EX-10.1
from 8-K 11 pages Collagenex Pharmaceuticals, Inc. Change of Control Agreement
12/34/56
EX-10.33
from 10-K 2 pages Executive Officer Compensation Summary
12/34/56
EX-10.32
from 10-K 2 pages Non-Employee Director Compensation Summary
12/34/56
EX-10.28
from 10-K 29 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Commercial Manufacturing Agreement
12/34/56
EX-10.27
from 10-K 5 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Amendment to License Agreement
12/34/56
EX-10.5
from 10-K 29 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions. Share Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages Collagenex Pharmaceuticals, Inc. Restructuring and Exchange Agreement
12/34/56
EX-10.1
from 8-K 7 pages Stock Option Agreement
12/34/56
EX-10
from 10-Q 2 pages Granted To: Robert A. Beardsley Grant Date: May 25, 2005 Options Granted: 12,000 Option Price Per Share: $4.5800 Total Cost to Exercise: $54,960.0000 Expiration Date: May 25, 2015 Vesting Schedule: 25% Per Year for 4 Years 3,000 on 05/25/2006 3,000 on 05/25/2007 3,000 on 05/25/2008 3,000 on 05/25/2009
12/34/56
EX-10
from 10-Q 2 pages June 29, 2005 James O’shea 112 Balls Hill Road Concord, Ma 01742 Granted To: James O’shea Grant Date: May 25, 2005 Options Granted: 12,000 Option Price Per Share: $4.5800 Total Cost to Exercise: $54,960.0000 Expiration Date: May 25, 2015 Vesting Schedule: 25% Per Year for 4 Years 3,000 on 05/25/2006 3,000 on 05/25/2007 3,000 on 05/25/2008 3,000 on 05/25/2009
12/34/56
EX-10
from 10-Q 2 pages June 29, 2005 Robert Easton 525 East 80th Street Apt. 9c New York, Ny 10021 Granted To: Robert Easton Grant Date: May 25, 2005 Options Granted: 12,000 Option Price Per Share: $4.5800 Total Cost to Exercise: $54,960.0000 Expiration Date: May 25, 2015 Vesting Schedule: 25% Per Year for 4 Years 3,000 on 05/25/2006 3,000 on 05/25/2007 3,000 on 05/25/2008 3,000 on 05/25/2009
12/34/56